Objectives: Human Plasmodium knowlesi infections have been reported from several South-East Asian countries, excluding India, but its drug susceptibility profile in mixed-infection cases remains unknown.
Introduction
Plasmodium knowlesi is a monkey malaria parasite, but it can also infect humans. 1, 2 It can cause very high parasitaemia in humans, leading to anaemia and other complications if left untreated. 3 The human P. knowlesi infections have been reported from several South-East Asian countries.
2,4 -12 Plasmodium falciparum and Plasmodium vivax are very common human malaria parasite species in these South-East Asian countries and their coinfection with P. knowlesi has also been reported. 6, 13 Separately, drug-resistant P. falciparum and P. vivax malaria and mutations in their marker genes have also been reported from South-East Asian countries. 14 -19 Under continuous drug pressure, the selection and spread of parasite populations with certain drug-resistant alleles occurs. For example, the selection of a P. falciparum population with mutant chloroquine resistance transporter (CRT) (Pfcrt) and dihydrofolate reductase (DHFR) (Pfdhfr) alleles associated with higher levels of chloroquine and pyrimethamine resistance, respectively, has been reported. 19 -21 Similar trends of antimalarial drug resistance-associated mutations in P. vivax have also been reported. 15 P. knowlesi seems to be susceptible to antimalarial drugs such as antifolates and chloroquine, as patients with monoinfections have been successfully treated with chloroquine. 22 However, the drug resistance status of this parasite in the case of mixed infections remains to be elucidated. This is important, as the coinfecting Plasmodium species may have already been drug resistant and could have gone through the selection process under drug # The Author 2013. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com J Antimicrob Chemother 2013; 68: 1081 -1088 doi:10.1093/jac/dks508 Advance Access publication 4 January 2013 pressure. Thus, determining the status of mutations in the drug resistance marker genes of P. knowlesi and of the coinfecting Plasmodium species present in the same patient may not only address the question of drug pressure on P. knowlesi, as for its coinfecting partner parasite, but might also give an insight into its transmission dynamics. The data thus obtained would help malaria control programmes to formulate an appropriate strategy to control this disease.
Human infections with P. knowlesi have not been reported from India so far, although such zoonotic infections have been reported from its neighbouring South-East Asian countries.
2,4 -12
Therefore, we studied human P. knowlesi infections from the Andaman and Nicobar Islands of India, because these islands are ecologically and geographically very close to these SouthEast Asian countries. We also investigated the drug resistance status of the Plasmodium parasites by analysing their respective marker genes.
Materials and methods

Study site
We used leftover archived parasite DNA, isolated from filter paper blood spots, collected from malaria patients from the Andaman and Nicobar Islands ( Figure S1 , available as Supplementary data at JAC Online). These samples were collected during our earlier analyses of mutations in the drug resistance-associated marker genes of the parasite population of these islands. 16, 20, 23 The leftover samples are, therefore, random and unplanned, which may cause bias in terms of the P. falciparum and P. vivax ratio and may not reflect the true epidemiological picture of the region. The Human Ethics Committee of the All India Institute of Medical Sciences, New Delhi approved the use of the leftover archived DNA samples for the study via approval numbers IEC/NP-342/ 2012 and RP-11/2012.
Light microscopy
Thin blood smears, made from the finger prick blood of patients and Giemsa stained, were observed under a light microscope at ×100 magnification with oil immersion.
PCR
Parasite DNA was subjected to PCR amplification of the 18S rRNA gene of all human Plasmodium species, including P. knowlesi, using the primers and reaction conditions described in Jongwutiwes et al. 7 These primers were different from those used in earlier studies 2,24 and did not cross-react with any of the other human Plasmodium species. The same DNA was used for the amplification of P. knowlesi genes encoding part of merozoite surface protein-1 (MSP-1) (Pkmsp-1), DHFR (Pkdhfr) and the CRT (Pkcrt). The PCR conditions and primer sequences used to amplify the P. knowlesi genes are given in Table S1 (available as Supplementary data at JAC Online). The PCR amplification of the Pfcrt and Pfdhfr genes of P. falciparum and the Pvdhfr gene of P. vivax was carried out as described previously, using the primers and conditions described therein. 15, 17, 23 A negative control was always used to rule out cross-contamination and the proofreading polymerase Pfx was used to minimize PCR-introduced mutations.
Nucleotide sequencing and sequence analysis DNA bands of the expected size were excised from the agarose gel and the DNA was purified using a gel extraction kit (Bioneer Corporation, South Korea), according to the manufacturer's protocol. This DNA was used to sequence the parasite genes. Primers Pk18SF and Pk18sRc for 18S rRNA, 7 Pkmsp1-3 and Pkmsp1-5 for Pkmsp-1, Pkdhfr-3 and Pkdhfr-4 for Pkdhfr and Pkcrt-3 and Pkcrt-4 for Pkcrt were used for P. knowlesi. Sequencing primers for the Pfcrt, Pfdhfr and Pvdhfr genes have been described previously. 15, 17, 23 The cycling parameters of the sequencing PCR and cleanup protocols were the same as described in Vinayak et al. 25 using the ABI Big Dye Terminator Ready Reaction Kit version 3.1 on a 3130xl Genetic Analyzer (Applied Biosystems, Forster City, CA, USA). The electropherograms were analysed using BioEdit Sequence Alignment Editor and the sequences analysed using GeneDoc version 2.6.002 software.
Accession numbers
The nucleotide sequences obtained in the present study from P. knowlesi isolates have been deposited in the GenBank database and are available under the following accession numbers: JQ321371 and JQ321372 for the Pk1 and Pk2 genotypes of 18S rRNA, respectively, JQ321373-JQ321375 for M1-M3 genotypes, respectively; JQ423940 for the M4 genotype and JQ423941 for the M5 genotype of MSP-1; JQ409298 and JQ409299 for the Pkdhfr-1 and Pkdhfr-2 genotypes of DHFR, respectively; and JQ409297 for the Pkcrt genotype of CRT. The P. knowlesi gene sequences used here for comparisons were retrieved from the GenBank database (http://www.ncbi.nlm.nih.gov/nuccore/[Accession number]) under accession numbers: FJ619097.1 for 18S rRNA; JF837344.1 for MSP-1; XM002258192.1 for DHFR; and XM002257531.1 for CRT.
2,26,27
Results
Human P. knowlesi infections
A total of 445 archived DNA samples, available from previous studies 16, 20, 23 on malaria patients from the Andaman and Nicobar Islands, were analysed. The parasite species distribution among these samples was as follows: 80.67% P. falciparum, 11.68% P. vivax and 7.64% mixed with both species. Fifty-three of the 445 (11.9%) DNA samples were PCR positive for the P. knowlesi 18S rRNA gene. The species-specific PCR showed that out of these 53 samples, 46 had P. knowlesi and P. falciparum, 4 had P. knowlesi and P. vivax and 3 had P. knowlesi monoinfection. None had Plasmodium malariae or Plasmodium ovale parasites. The distribution of these human P. knowlesi infections on the islands showed that out of these 53 samples, this species was more common in Car Nicobar than in Port Blair ( Figure 1 ). This difference in the percentage prevalence rate could be due to differences in the tribal and non-tribal human populations of the islands. For example, the human population of Port Blair is predominantly nontribal, whereas the human population of Car Nicobar is mainly tribal.
The specificity of the PCR for P. knowlesi 18S rRNA was confirmed by sequencing its amplified product. The obtained sequence matched that of the P. knowlesi 18S rRNA gene ( Figure 2a ). These sequences were different from those of other Plasmodium species. There were two different genotypes among the isolates. Sixteen isolates had the same sequence as reference strain H of monkey P. knowlesi (Pk1 genotype) and 37 isolates had a variant form (Pk2 genotype). This ruled out the possibility of contamination as well as primer cross-reactivity.
To further confirm that these samples were indeed infected with P. knowlesi, we amplified and sequenced part of its Pkmsp-1 gene. The Pkmsp-1 gene was sequenced from 38 isolates and shown to match with that of monkey P. knowlesi msp-1 (Figure 2b ). These sequences differed from the msp-1 sequence 
Drug resistance-associated mutations in coinfecting Plasmodium species
The PCR amplification and sequencing of the Pkcrt and Pkdhfr genes occurred successfully in 26 and 29 samples, respectively. The sequences of both genes from these clinical isolates matched completely with the sequence of reference strain H of monkey P. knowlesi (Figure 2c and d ), but were different from that of the human Plasmodium species. Nevertheless, there was a T-to-C change at the third position of codon 135 of Pkdhfr, resulting in two different genotypes (Pkdhfr-1 and Pkdhfr-2) without any amino acid change.
The corresponding drug resistance marker genes of P. falciparum were also sequenced from those samples that were coinfected with P. knowlesi ( Table 1) . Forty of 46 samples having P. falciparum and P. knowlesi infections showed PCR amplification of Pfcrt. The Pfcrt sequence of these 40 isolates revealed that the majority of them (92.5%) had mutations at amino acid positions 72-76, resulting in two different genotypes: SVMNT and CVIET (the mutated amino acids are underlined). Isolates with the highly drug-resistant CVIET genotype were more predominant (70%) than those with the SVMNT genotype (22.5%). Twenty-three of these 40 isolates also showed PCR amplification of the Pkcrt gene. As mentioned above, all 26 clinical isolates, including these 23 samples, showed the wild-type Pkcrt sequence at this locus (Table 1) .
Thirty-nine of the 46 samples having P. falciparum and P. knowlesi mixed infections showed PCR amplification of Pfdhfr. The majority of samples (38/39, 97.43%) had mutations in this gene. The wild-type sequence ANCSI at amino acid positions 16, 51, 59, 108 and 164 was present in only one sample. Among these 39 samples, 58.97% had the quadruple mutation AIRNL while 33.33% samples had the double mutation ANRNI (the mutated amino acids are underlined). The triple mutations ANRNL or AIRNI were present in a single sample each. Twentyfour of these 39 isolates also showed PCR amplification of the Pkdhfr gene, whose sequence was wild-type (Table 1) . Indeed, the Pkdhfr sequence of the remaining 5 (total of 29) samples was also wild-type. Thus, in most of the mixed-infection cases, P. falciparum had drug-resistant Pfcrt and Pfdhfr genes while all cases of P. knowlesi had wild-type Pkcrt and Pkdhfr genes.
Three of four samples (having P. vivax and P. knowlesi infections) showed PCR amplification of the Pvdhfr gene and two samples showed PCR amplification of the Pkdhfr gene. While the Pkdhfr gene was wild-type in both samples, the Pvdhfr gene was wild-type in one sample but showed double mutations in the other two isolates (data not shown).
Unusual parasite morphology
The re-examination of some of the available slides from the patients under light microscopy revealed some unusual parasite morphology, such as amoeboid structures [ Figure S2e and f (available as Supplementary data at JAC Online)], thick chromatin ( Figure S2a -d and g -i) and extended cytoplasm ( Figure S2a , b and d), which are generally not seen in other human Plasmodium species and could be indicative of P. knowlesi. In one case, we observed unusual band formation ( Figure S2h ). This band formation is different from that of P. malariae. It may, however, be noted that this type of band formation was not common in all the P. knowlesi slides; therefore, at present we cannot propose Mutation patterns in crt and dhfr of P. falciparum and P. knowlesi its use as a unique morphological feature for the routine microscopic diagnosis of this parasite. As expected, none of the slides was found to contain P. malariae, as was also ruled out by the above-mentioned molecular data on these samples. The morphological features and above-mentioned molecular differences established the presence from P. knowlesi in these malaria patients from the Andaman and Nicobar Islands.
Discussion
For the first time, we describe the existence of human P. knowlesi infections in India. The gene sequences obtained from malaria patients were indistinguishable from those of monkey P. knowlesi (Figure 2) . Similarly, there were some unusual morphological features of the parasite that did not match with human Plasmodium species and could be indicative of P. knowlesi [ Figure S2 (available as Supplementary data at JAC Online)]. In 1980, Kalra 28 reported the emergence of a malaria zoonosis of simian origin (Plasmodium cynomolgi) as a natural phenomenon in Greater Nicobar of the Andaman and Nicobar Islands, due to the presence of the crab-eating macaque monkey and the susceptible Anopheles mosquito vector. It is quite possible that the P. cynomolgi parasite reported by Kalra was indeed P. knowlesi, since it is difficult to distinguish these parasites by light microscopy. The probability Tyagi et al.
of a malaria zoonosis involving P. knowlesi on these islands is very high, since they are very close to the South-East Asian countries ( Figure S1 , available as Supplementary data at JAC Online) where P. knowlesi human infections have already been reported. 4 -10,12 We do not know if the parasite reservoir in monkeys existed on these islands independently or if this parasite migrated from neighbouring South-East Asian countries. It may be noted that the Andaman and Nicobar Islands share a similar flora and fauna with these South-East Asian countries; the crab-eating macaque monkey, which could be a primary host, and the Leucosphyrus group of Anopheles mosquito vectors, which can transmit the disease, have been reported from the Andaman and Nicobar Islands. 28 -30 It is interesting to note that poachers from Thailand and Indonesia come to these islands for the collection of sea and forest wealth. They temporarily migrate to these islands and stay for a certain period of time before returning to their country. Probably, P. knowlesi was introduced to the Andaman and Nicobar Islands through these poachers.
After establishing the existence of human P. knowlesi infections, we were interested to determine the mutation patterns of drug resistance marker genes, which could provide indirect evidence of the drug susceptibility profile of this parasite. Previously, we have reported on mutations in critical amino acid residues of these marker genes and their association with drug resistance in P. falciparum. 14, 16, 17 We observed similar trends in the mutation patterns of the drug resistance marker gene of P. vivax. 15 We were therefore interested to determine the presence of mutation patterns in the drug resistance markers of all the Plasmodium species found in our samples. The Pfcrt and Pfdhfr genes of P. falciparum, associated with chloroquine and pyrimethamine resistance, respectively, were found to contain Mutation patterns in crt and dhfr of P. falciparum and P. knowlesi drug-resistant alleles in the majority of the patients who had P. knowlesi and P. falciparum mixed infections (Table 1) . On the other hand, all sequences of the Pkcrt and Pkdhfr genes of P. knowlesi were wild-type for all the isolates sequenced. This is in accordance with our previous findings, where we reported the presence and selection of such P. falciparum populations having resistant alleles as well as treatment failures from these regions of India. 15 -17,20,21 However, it was surprising to find wildtype Pkcrt and Pkdhfr genes in all the clinical isolates obtained from patients with either mono P. knowlesi infections or its coinfection with other Plasmodium species. These data suggest that the P. knowlesi parasite present in human patients, either as a mono-or mixed infection, probably will be susceptible to the antimalarial drugs while the coinfecting parasite will be resistant to them. These findings are corroborated by the reported literature where human P. knowlesi infections were successfully treated with chloroquine. 22 These results also indicate that P. knowlesi has not been under continuous drug pressure, which otherwise would have allowed the selection of parasite populations with mutant Pkcrt or Pkdhfr genotypes, as seen in other Plasmodium species.
These findings also suggest that there could have been mostly a monkey-to-human P. knowlesi transmission through the Anopheles vector. This is because the monkeys are not treated with any antimalarial drug and, in the absence of drug pressure, the probability of the P. knowlesi-infected monkeys carrying the wild-type Pkcrt gene remains very high. On the other hand, human-to-human transmission could have resulted in the selection of P. knowlesi populations with drug-resistant Pkcrt and Pkdhfr alleles due to continuous drug pressure, as observed in the P. falciparum population (Table 1) . Nevertheless, at present, a weak transmission of P. knowlesi with wild-type Pkcrt and Pkdhfr from human to human cannot be completely ruled out.
The observed discordant mutation pattern in the drug resistance marker genes of P. knowlesi and P. falciparum indicates that the patients are infected with two different Plasmodium species where one is probably susceptible to the drug while the other is resistant. This differential drug susceptibility genotype profile should be confirmed by in vivo studies. Nevertheless, it should be considered by the malaria control programme of the concerned country having such a discordant mutation pattern, when formulating the correct antimalarial drug policy. This is because P. knowlesi is susceptible to most of the antimalarial drugs and need not be exposed to artesunate-based combination therapy. If diagnosed at an early stage, a simple old antimalarial drug treatment should be given to monoinfected patients in order to prevent the parasite developing resistance against these advanced antimalarials. For this, specific rapid diagnostic tests need to be developed, since it is difficult to distinguish P. knowlesi from other Plasmodium species by routine light microscopy. These methods could be based on speciesspecific PCR or dipstick that includes a supplementary band for P. knowlesi detection. However, these methods should be adaptable by the malaria control programmes in the field.
In conclusion, a larger number of countries and thus a larger human population in South-East Asia are at a risk of having this simian (P. knowlesi) malaria than reported so far. Furthermore, the drug resistance pattern of this parasite seems to be different from that of the coinfecting parasite. The establishment of human P. knowlesi infection has raised a pertinent issue for malaria control programmes, as this parasite may behave differently if efficient human-to-human transmission occurs in the future. Therefore, control programmes should employ the appropriate methods to diagnose P. knowlesi infection at an early stage and formulate a suitable antimalarial drug policy. Mutation patterns in crt and dhfr of P. falciparum and P. knowlesi
